Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
Titel:
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
Auteur:
Nicholls, Stephen J. Bhatt, Deepak L Buse, John B Prato, Stefano Del Kahn, Steven E Lincoff, A Michael McGuire, Darren K Nauck, Michael A Nissen, Steven E Sattar, Naveed Zinman, Bernard Zoungas, Sophia Basile, Jan Bartee, Amy Miller, Debra Nishiyama, Hiroshi Pavo, Imre Weerakkody, Govinda Wiese, Russell J D'Alessio, David